Regional Reference Centre for Inherited Bleeding Disorders, University Hospital, Parma, Italy.
Haemophilia. 2010 May;16(3):437-46. doi: 10.1111/j.1365-2516.2009.02188.x. Epub 2010 Feb 9.
Although a number of studies have analysed so far the causes of death and the life expectancy in haemophilic populations, no investigations have been conducted among Italian haemophilia centres. Thus, the aim of this study was to investigate mortality, causes of deaths, life expectancy and co-morbidities in Italian persons with haemophilia (PWH). Data pertaining to a total of 443 PWH who died between 1980 and 2007 were retrospectively collected in the 30 centres who are members of the Italian Association of Haemophilia Centres that chose to participate. The mortality rate ratio standardized to the male Italian population (SMR) was reduced during the periods 1990-1999 and 2000-2007 such that during the latter, death rate overlapped that of the general population (SMR 1990-1999: 1.98 95% CI 1.54-2.51; SMR 2000-2007: 1.08 95% CI 0.83-1.40). Similarly, life expectancy in the whole haemophilic population increased in the same period (71.2 years in 2000-2007 vs. 64.0 in 1990-1999), approaching that of the general male population. While human immunodeficiency virus infection was the main cause of death (45%), 13% of deaths were caused by hepatitis C-associated complications. The results of this retrospective study show that in Italian PWH improvements in the quality of treatment and global medical care provided by specialized haemophilia centres resulted in a significantly increased life expectancy.
尽管目前已有多项研究分析了血友病患者的死亡原因和预期寿命,但意大利的血友病中心尚未开展此类调查。因此,本研究旨在调查意大利血友病患者(PWH)的死亡率、死亡原因、预期寿命和合并症。在选择参与的意大利血友病中心协会的 30 个中心中,回顾性收集了 1980 年至 2007 年间总共 443 名死亡的 PWH 的数据。1990-1999 年和 2000-2007 年期间,标准化死亡率与意大利男性人口(SMR)的比值降低,使得后者的死亡率与普通人群重叠(SMR 1990-1999:1.98,95%CI 1.54-2.51;SMR 2000-2007:1.08,95%CI 0.83-1.40)。同样,同一时期整个血友病患者的预期寿命也有所增加(2000-2007 年为 71.2 岁,1990-1999 年为 64.0 岁),接近普通男性人口的预期寿命。尽管人类免疫缺陷病毒感染是主要的死亡原因(45%),但仍有 13%的死亡归因于丙型肝炎相关并发症。本回顾性研究的结果表明,意大利 PWH 的治疗质量和由专业血友病中心提供的整体医疗护理得到改善,从而显著提高了预期寿命。